These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27358188)

  • 1. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.
    Rollin J; Pouplard C; Gratacap MP; Leroux D; May MA; Aupart M; Gouilleux-Gruart V; Payrastre B; Gruel Y
    Blood; 2012 Aug; 120(6):1309-16. PubMed ID: 22677127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
    Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
    Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The homozygous FcgammaRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin-platelet factor 4 complexes.
    Gruel Y; Pouplard C; Lasne D; Magdelaine-Beuzelin C; Charroing C; Watier H
    Blood; 2004 Nov; 104(9):2791-3. PubMed ID: 15191947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
    Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
    J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.
    Tutwiler V; Madeeva D; Ahn HS; Andrianova I; Hayes V; Zheng XL; Cines DB; McKenzie SE; Poncz M; Rauova L
    Blood; 2016 Jan; 127(4):464-72. PubMed ID: 26518435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc gamma RIIA H/R 131 polymorphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis.
    Arepally G; McKenzie SE; Jiang XM; Poncz M; Cines DB
    Blood; 1997 Jan; 89(2):370-5. PubMed ID: 9002937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
    Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
    J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.
    Rollin J; Pouplard C; Sung HC; Leroux D; Saada A; Gouilleux-Gruart V; Thibault G; Gruel Y
    Blood; 2015 Apr; 125(15):2397-404. PubMed ID: 25680756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism.
    Carlsson LE; Santoso S; Baurichter G; Kroll H; Papenberg S; Eichler P; Westerdaal NA; Kiefel V; van de Winkel JG; Greinacher A
    Blood; 1998 Sep; 92(5):1526-31. PubMed ID: 9716579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis.
    Bachelot-Loza C; Saffroy R; Lasne D; Chatellier G; Aiach M; Rendu F
    Thromb Haemost; 1998 Mar; 79(3):523-8. PubMed ID: 9531034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia.
    Arepally GM
    Blood; 2017 May; 129(21):2864-2872. PubMed ID: 28416511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
    Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
    Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
    Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
    Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia.
    Perdomo J; Leung HHL; Ahmadi Z; Yan F; Chong JJH; Passam FH; Chong BH
    Nat Commun; 2019 Mar; 10(1):1322. PubMed ID: 30899022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.
    Madeeva D; Cines DB; Poncz M; Rauova L
    Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.
    Slavik L; Svobodova G; Ulehlova J; Krcova V; Hlusi A; Prochazkova J; Hutyra M
    Clin Lab; 2015; 61(8):1027-32. PubMed ID: 26427148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.
    Kasthuri RS; Glover SL; Jonas W; McEachron T; Pawlinski R; Arepally GM; Key NS; Mackman N
    Blood; 2012 May; 119(22):5285-93. PubMed ID: 22394597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT).
    Müller L; Dabbiru VAS; Schönborn L; Greinacher A
    Expert Opin Pharmacother; 2024 Feb; 25(3):281-294. PubMed ID: 38465524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia--review].
    Lei Q; Chen L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):457-60. PubMed ID: 18426686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.